loading

Cyclo Therapeutics Inc Azioni (CYTH) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
34.99%
0.2025
0.3114 0.4955 0.1171 0.1524
Cost Of Revenue
0.0118
- - - -
Gross Profit
0.1906
- - - -
Operating Expenses
9.50%
5.3117
5.8696 5.2629 4.7501 5.1595
Benefits Costs and Expenses
23.65%
4.5455
5.9538 5.2668 4.7536 5.1595
Costs And Expenses
9.50%
5.3117
5.8696 5.2629 4.7501 5.1595
Operating Income/Loss
9.24%
-5.1211
-5.6425 -4.7675 -4.6329 -5.0071
Nonoperating Income/Loss
682.36K%
0.778
0.000114 -0.00389 -0.00351 0.000047
Income/Loss From Continuing Operations Before Tax
23.03%
-4.3431
-5.6424 -4.7714 -4.6365 -5.0071
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
23.03%
-4.3431
-5.6424 -4.7714 -4.6365 -5.0071
Net Income/Loss
23.03%
-4.343
-5.6423 -4.771 -4.6365 -5.0071
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,377%
28.59
1.9348 16.19 14.04 11.00
Basic Earnings Per Share
34.78%
-0.15
-0.23 -0.29 -0.33 -0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$11.63
price down icon 1.61%
$89.28
price down icon 2.89%
$83.45
price down icon 0.82%
drug_manufacturers_specialty_generic RDY
$15.37
price up icon 1.65%
$135.42
price up icon 0.34%
$12.52
price up icon 3.22%
Capitalizzazione:     |  Volume (24 ore):